Strengthening and Enhancing National HIV/AIDS Prevention, Diagnosis, Care, Treatment, Monitoring and Surveillance of Communicable and Non-communicable Diseases with the Ministry of Health in the Republic of Haiti under the President's Emergency Plan | CDC RFA GH15 152703CONT17

Opportunity Information: Apply for CDC RFA GH15 152703CONT17

The grant opportunity titled "Strengthening and Enhancing National HIV/AIDS Prevention, Diagnosis, Care, Treatment, Monitoring and Surveillance of Communicable and Non-communicable Diseases with the Ministry of Health in the Republic of Haiti under the President's Emergency Plan" is a continuation funding action released by the U.S. Department of Health and Human Services through the Centers for Disease Control and Prevention (CDC), specifically under CDC's Center for Global Health. It sits within the broader framework of the President's Emergency Plan for AIDS Relief (PEPFAR) and is focused on supporting Haiti's Ministry of Health in strengthening national systems that address HIV/AIDS as well as related public health priorities, including both communicable and non-communicable diseases. The overarching intent is to reinforce the infrastructure and capabilities needed to prevent new HIV infections, improve diagnosis and linkage to care, ensure effective treatment, and strengthen monitoring and surveillance functions that guide public health decision-making.

This opportunity is not an open, competitive solicitation for new organizations. It is explicitly designed as continuation funding for entities that were already funded under the earlier award announcement CDC-RFA-GH15-1527. In practical terms, that means only prior grantees from that specific program are intended to receive additional support under this continuation notice. The listing of eligible applicants as "Others" is clarified by that limitation: eligibility is constrained to incumbent awardees, rather than being broadly available to the public or to new applicants seeking entry into the program. The opportunity category is labeled "Continuation," reinforcing that this action is meant to extend or maintain ongoing work rather than launch a new set of projects.

The funding mechanism is a cooperative agreement, which is important because it signals an active partnership model between CDC and the funded recipients. Under a cooperative agreement, CDC typically has substantial programmatic involvement, such as providing technical assistance, collaborating on implementation approaches, setting performance expectations, and working closely on monitoring progress and results. This is especially relevant in health system strengthening efforts, where technical guidance, harmonization with national strategies, and alignment with PEPFAR targets and reporting structures often require close coordination between the funder and implementing partners. The activity category is health, and the CFDA number associated with the opportunity is 93.067, which corresponds to CDC global health-related assistance.

From a programmatic perspective, the work supported by this continuation award centers on reinforcing Haiti's capacity to deliver comprehensive HIV services and to maintain the data and surveillance systems needed to track the epidemic and measure program outcomes. That typically includes strengthening HIV prevention interventions, expanding or improving HIV testing and diagnosis strategies, ensuring timely linkage to care, and supporting sustained antiretroviral therapy (ART) delivery with an emphasis on retention and viral suppression. It also emphasizes monitoring and surveillance, which can include strengthening routine health information systems, improving case reporting and program data quality, supporting laboratory networks and diagnostic systems, and enhancing the ability to analyze and use data for planning and resource allocation. The title also explicitly references communicable and non-communicable diseases beyond HIV, indicating an integrated approach where investments in systems (labs, surveillance platforms, clinical capacity, and monitoring structures) can support a wider set of health priorities in Haiti.

Administrative details in the notice provide a snapshot of the opportunity's scale and timing. The funding opportunity number is CDC RFA GH15 152703CONT17, indicating it is a continuation related to the earlier GH15-1527 announcement. The opportunity was created on February 7, 2017, and the original closing date was April 11, 2017. The expected number of awards is listed as 10, suggesting that up to ten existing recipients under the prior announcement were anticipated to receive continuation funding. The award ceiling is listed as 0, which in many grant postings indicates that a specific maximum amount per award is not being stated in the public synopsis, or that funding levels are determined through internal continuation processes tied to prior awards, budgets, and available appropriations rather than through a new competitive cap.

In plain terms, this CDC PEPFAR continuation opportunity is best understood as a mechanism to keep previously funded Haiti-focused HIV and health systems strengthening activities running, while maintaining CDC involvement through a cooperative agreement structure. It is designed to sustain and enhance national capacity in prevention, diagnosis, treatment, monitoring, and surveillance in collaboration with Haiti's Ministry of Health, rather than to recruit new applicants or initiate a brand-new program.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Strengthening and Enhancing National HIV/AIDS Prevention, Diagnosis, Care, Treatment, Monitoring and Surveillance of Communicable and Non-communicable Diseases with the Ministry of Health in the Republic of Haiti under the President's Emergency Plan" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Feb 07, 2017.
• Applicants must submit their applications by Apr 11, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH15 152703CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: